Joslyn Alan 4
4 · ORAGENICS INC · Filed Mar 27, 2019
Insider Transaction Report
Form 4
ORAGENICS INCOGEN
Joslyn Alan
DirectorCEO and President
Transactions
- Purchase
Series 2 Common Stock Warrants (right to buy)
2019-03-25+33,333→ 50,000 totalExercise: $0.90From: 2019-03-25Exp: 2024-03-25→ Common Stock (33,333 underlying) - Purchase
Common Stock
2019-03-25+66,667→ 66,667 total - Purchase
Series 1 Common Stock Warrants (right to buy)
2019-03-25+33,333→ 50,000 totalExercise: $0.75From: 2019-03-25Exp: 2020-09-25→ Common Stock (33,333 underlying)
Footnotes (1)
- [F1]Purchase of Units consisting of one share of common stock and Series 1 Warrant to purchase one-half of a share of our Common Stock (exercisable through the earlier of 20 days post read out of AG013 clinical trial data or eighteen months) and a Series 2 Warrant to purchase one-half of a share of our Common Stock in an underwritten public offering at the price of $0.75 per Unit, which was the price paid by the public for such Units.